Skin cancer, wound healing, inflammatory skin disease
SKINTEGRITY.CH is a collaborative research initiative, which brings together experts from different disciplines from Swiss and selected external institutions to address the following overarching aims:
SKINTEGRITY.CH is based on the Zurich Initiative “SKINTEGRITY”, which was selected as flagship project of “Hochschulmedizin Zürich” (University Medicine Zurich) in 2016. Due to its remarkable success and positive evaluation of new projects, the program was prolonged and extended to various Swiss universities and research institutions in 2021.
SKINTEGRITY.CH unites leading experts in basic science, engineering and clinical medicine with the aim to better understand, diagnose and treat major human skin diseases, including various types of skin cancer. It also provides unique training opportunities for young investigators at the interface between disciplines. The project strongly benefits from the knowledge and expertise of researchers from twelve Swiss universities/research institutions.
Dr. Maarten Schledorn, Scientific Coordinator of SKINTEGRITY.CH
From: Ramelyte, E., Tastanova, A., Balázs, Z., Ignatova, D., Turko, P., Menzel, U., Guenova, E., Beisel, C., Krauthammer, M., Levesque, M. P., & Dummer, R. (2021). Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective. Cancer Cell, 39(3), 394-406. https://doi.org/10.1016/j.ccell.2020.12.022 (Authors in bold are SKINTEGRITY.CH Principal or Young Investigators)